Adapthealth (AHCO)
NASDAQ:AHCO
Want to see AHCO full AI Analyst Report?
AHCO Stock Chart & Stats
$12.66
$0.16(1.59%)
At close: 4:00 PM EST
$12.66
$0.16(1.59%)
Day’s Range― - ―
52-Week Range$8.06 - $13.43
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.35M
Market Cap
$1.31B
Enterprise Value$3.25B
Total Cash (Recent Filing)$47.96M
Total Debt (Recent Filing)$2.00B
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 11, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding136,054,150
10 Day Avg. Volume1,262,265
30 Day Avg. Volume1,348,297
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.89
Price to Sales (P/S)0.41
P/FCF Ratio6.14
Enterprise Value/Market Cap2.47
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit21.10
Enterprise Value/Ebitda7.03
Forecast
1Y Price Target
$14.67Price Target Upside15.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.87
Revenue Forecast (FY)$3.48B
Bulls Say, Bears Say
Bulls Say
Core Business FocusAdapt is focusing on core business areas like Sleep, Respiratory, Diabetes, and Wellness at Home, which is leading to improved financial performance and patient service.
Deleveraging EffortsAdapt's deleveraging efforts are reducing the company's risk profile, which could lead to multiple expansion in the future.
Technology And AI ImplementationThe reorganization and standardization efforts are expected to enable effective implementation of AI and technology, improving margins and insulating profitability.
Bears Say
Earnings PerformanceEPS of $0.11 came in below both the estimate and consensus.
EBITDA ForecastsLowering estimates for 2025-26 EBITDA forecasts, which affects the financial outlook despite maintaining the price target.
Revenue OutlookAdapthealth lowered its 2025 revenue outlook by about 1% at the midpoint.
AdaptHealth News
AHCO FAQ
What was Adapthealth’s price range in the past 12 months?
Adapthealth lowest stock price was $8.06 and its highest was $13.43 in the past 12 months.
What is Adapthealth’s market cap?
Adapthealth’s market cap is $1.31B.
When is Adapthealth’s upcoming earnings report date?
Adapthealth’s upcoming earnings report date is Aug 11, 2026 which is in 51 days.
How were Adapthealth’s earnings last quarter?
Adapthealth released its earnings results on May 05, 2026. The company reported -$0.056 earnings per share for the quarter, missing the consensus estimate of $0.012 by -$0.068.
Is Adapthealth overvalued?
According to Wall Street analysts Adapthealth’s price is currently Undervalued.
Does Adapthealth pay dividends?
Adapthealth does not currently pay dividends.
What is Adapthealth’s EPS estimate?
Adapthealth’s EPS estimate is 0.15.
How many shares outstanding does Adapthealth have?
Adapthealth has 136,054,150 shares outstanding.
What happened to Adapthealth’s price movement after its last earnings report?
Adapthealth reported an EPS of -$0.056 in its last earnings report, missing expectations of $0.012. Following the earnings report the stock price went down -9.893%.
Which hedge fund is a major shareholder of Adapthealth?
Currently, no hedge funds are holding shares in AHCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.67 (15.85% Upside)
$14.67 (15.85% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 121.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $4.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.79%
12-Months-Change
Fundamentals
Return on Equity
-5.11%
Trailing 12-Months
Asset Growth
-0.30%
Trailing 12-Months
Company Description
Adapthealth
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights a major strategic win — completion of a large capitated transition, robust organic revenue growth (9.1% y/y), strong segment performance (notably Sleep and Respiratory), important technology milestones, and a refinancing that improves financial flexibility. Near-term challenges include elevated transition-related labor costs ($12M), a Q1 adjusted EBITDA miss (~$7M), negative free cash flow in the quarter due to elevated CapEx ($121.2M), and a temporary increase in leverage to ~3.0x. Management expects labor costs and CapEx to normalize by mid-year, maintains full-year EBITDA and free cash flow guidance, and raised revenue guidance slightly. Overall, strategic progress and forward-looking actions appear to outweigh the near-term execution and cash impacts.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$14.67
▲(15.85% Upside)
Technical Analysis
Ownership Overview
15.03% Insiders
22.38% Mutual Funds
29.99% Other Institutional Investors
9.88% Public Companies and
Individual Investors